GlycoMantra has been awarded a two-year SBIR Phase 2 grant ($3.7 M) from the NIDDK…
July 2017
GlycoMantra received Investor Initiative Award from the NCI (NIH).
Through this mechanism, NCI will showcase GlycoMantra in front of the investors in relevant meetings like BIO, RESI.
